Carvix3.125/6.25

Carvix3.125/6.25

B

        For Long Term Management of HF & LVD

Carvix

  Carvedilol 3.125 mg tablets.

Hours Superior Cardiac Care

  • Controlled release formulation approved by USFDA
  • 24 Hour a1 & B blockade
  • Greater compliance & adherence
  • Significantly lower* NTproBNP & central augmented pressure than any other beta blockers in Heart Failure.
  • Reduces oxidative stress, improves endothelial function, insulin sensitivity & total cholesterol.
  • Decrease the risk of death by 30% and risk of hospitalization by 24% in Heart Failure
  • Well tolerated in COPD with Heart Failure Patients.
  • May 12, 2016